Abstract:Avian pathogenic Escherichia coli, a causative agent of avian colibacillosis, has been causing serious economic losses in the poultry industry. The increase in multidrug-resistant isolates and the complexity of the serotypes of this pathogen, especially the recently reported emergence of a newly predominant serogroup of O145, make the control of this disease difficult. To address this challenge, a high-throughput screening approach, called Pan-RV (Reverse vaccinology based on pangenome analysis), is proposed to search for universal protective antigens against the three traditional serogroups and the newly emerged O145. Using this approach, a total of 61 proteins regarded as probable antigens against the four important serogroups were screened from the core genome of 127 Avian pathogenic Escherichia coli (APEC) genomes, and six were verified by Western blots using antisera. Overall, our research will provide a foundation for the development of an APEC subunit vaccine against avian colibacillosis. Given the exponential growth of whole-genome sequencing (WGS) data, our Pan-RV pipeline will make screening of bacterial vaccine candidates inexpensive, rapid, and efficient. IMPORTANCE With the emergence of drug resistance and the newly predominant serogroup O145, the control of Avian pathogenic Escherichia coli is facing a serious challenge; an efficient immunological method is urgently needed. Here, for the first time, we propose a high-throughput screening approach to search for universal protective antigens against the three traditional serogroups and the newly emerged O145. Importantly, using this approach, a total of 61 proteins regarded as probable antigens against the four important serogroups were screened, and three were shown to be immunoreactive with all antisera (covering the four serogroups), thereby providing a foundation for the development of APEC subunit vaccines against avian colibacillosis. Further, our Pan-RV pipeline will provide immunological control strategies for pathogens with complex and variable genetic backgrounds such as Escherichia coli and will make screening of bacterial vaccine candidates more inexpensive, rapid, and efficient.

Sifting through the core-genome to identify putative cross-protective antigens against Riemerella anatipestifer

Identification and Evaluation of Novel Antigen Candidates Against Salmonella Pullorum Infection Using Reverse Vaccinology.

Immunoproteomics Selection of Cross-Protective Vaccine Candidates from Riemerella Anatipestifer Serotypes 1 and 2.

Porin protein could be a vaccine candidate against Riemerella anatipestifer for ducks

Immunoproteomic identification of 11 novel immunoreactive proteins of Riemerella anatipestifer serotype 2.

Combining Pangenome Analysis to Identify Potential Cross-Protective Antigens Against Avian Pathogenic Escherichia Coli

Identification of Subunits for Novel Universal Vaccines Against Three Predominant Serogroups and the Emerging O145 among Avian Pathogenic Escherichia Coli by Pan-RV Pipeline

The Screening of the Protective Antigens of Aeromonas hydrophila Using the Reverse Vaccinology Approach: Potential Candidates for Subunit Vaccine Development

In Silico Analysis and Immune Response of YaeT Protein Against Riemerella anatipestifer in Ducks

Two Novel Cross-Protective Antigens for Bovine Pasteurella Multocida

Genetic loci of the R. anatipestifer serotype discovered by Pan-GWAS and its application for the development of a multiplex PCR serotyping method

Isolation, Identification, and Proteomic Analysis of Outer Membrane Vesicles of Riemerella Anatipestifer SX-1

Identification of a Gene in Riemerella Anatipestifer CH-1 (B739-2187) That Contributes to Resistance to Polymyxin B and Evaluation of Its Mutant As a Live Attenuated Vaccine.

Screening of immunogenic proteins and evaluation of vaccine candidates against Mycoplasma synoviae

A Novel Pan-Genome Reverse Vaccinology Approach Employing a Negative-Selection Strategy for Screening Surface-Exposed Antigens Against Leptospirosis

Identification of Cross-Protective Potential Antigens against Pathogenic Brucella spp. through Combining Pan-Genome Analysis with Reverse Vaccinology

Immunogenicity of live<i> phoP</i> gene deletion strain of<i> Riemerella</i><i> anatipestifer</i> serotype 1

Development and Application of an Indirect ELISA for Detection of Riemerella Anatipestifer Serotype 1

Screening of potential vaccine candidates against pathogenic Brucella spp. using compositive reverse vaccinology

Identification and Immunological Characteristics of Chaperonin Groel in Riemerella Anatipestifer